Additional Post Hoc Analysis and Clinical Data Collection (BNA™)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02860416|
Recruitment Status : Completed
First Posted : August 9, 2016
Last Update Posted : June 6, 2019
|Condition or disease|
To collect additional Investigational cognitive tasks and additional clinical data for subjects tested with ElMindA's Brain Network Activation (BNA™).
The BNA™ technology was developed and is utilized by ElMindA Ltd. The (BNA™) Analysis System is cleared for use by qualified medical professionals for the post hoc statistical analysis of the human electroencephalogram ("EEG"), utilizing evoked response potentials ("ERP').
|Study Type :||Observational|
|Actual Enrollment :||55 participants|
|Official Title:||Additional Post Hoc Analysis and Clinical Data Collection for Subjects Tested With Brain Network Activation (BNA™) Technology|
|Study Start Date :||July 2016|
|Actual Primary Completion Date :||September 2018|
|Actual Study Completion Date :||October 2018|
- engineering development according to clinical assessments [ Time Frame: 2 years ]The study is designed to collect data that will aid in future scientific and engineering exploration of correlations between clinical assessments and BNA scores. The results are primarily intended for scientific inquiry and engineering development purposes.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02860416
|United States, Illinois|
|Glenview, Illinois, United States, 60026|
|United States, Nebraska|
|Premier Psychiatric Group|
|Lincoln, Nebraska, United States, 68526|
|Principal Investigator:||Mark Skopin, PhD||ElMindA Ltd|